A detailed history of Darwin Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Darwin Advisors, LLC holds 3,037 shares of JNJ stock, worth $475,989. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,037
Holding current value
$475,989
% of portfolio
0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$145.48 - $167.38 $441,822 - $508,333
3,037 New
3,037 $492,000
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $24,835 - $26,038
160 Added 5.68%
2,978 $471,000
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $31,449 - $34,318
-216 Reduced 7.12%
2,818 $441,000
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $3,893 - $4,362
-25 Reduced 0.82%
3,034 $472,000
Q2 2023

Jul 12, 2023

SELL
$154.35 - $166.11 $9,415 - $10,132
-61 Reduced 1.96%
3,059 $506,000
Q1 2023

Apr 18, 2023

SELL
$151.05 - $180.26 $7,099 - $8,472
-47 Reduced 1.48%
3,120 $483,000
Q4 2022

Jan 17, 2023

SELL
$160.2 - $179.79 $137,131 - $153,900
-856 Reduced 21.28%
3,167 $0
Q3 2022

Oct 18, 2022

SELL
$161.33 - $179.52 $8,873 - $9,873
-55 Reduced 1.35%
4,023 $670,000
Q2 2022

Aug 03, 2022

SELL
$168.19 - $186.01 $1.3 Million - $1.44 Million
-7,722 Reduced 65.44%
4,078 $705,000
Q1 2022

May 04, 2022

SELL
$158.14 - $179.59 $169,526 - $192,520
-1,072 Reduced 8.33%
11,800 $2.09 Million
Q4 2021

Jan 21, 2022

SELL
$155.93 - $173.01 $1.19 Million - $1.32 Million
-7,618 Reduced 37.18%
12,872 $2.13 Million
Q3 2021

Oct 27, 2021

SELL
$161.5 - $179.47 $93,670 - $104,092
-580 Reduced 2.75%
20,490 $3.31 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $1.82 Million - $1.95 Million
11,416 Added 118.25%
21,070 $3.47 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $9,337 - $10,399
61 Added 0.64%
9,654 $1.59 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $19,880 - $22,820
-145 Reduced 1.49%
9,593 $1.51 Million
Q3 2020

Oct 16, 2020

SELL
$140.38 - $153.83 $118,199 - $129,524
-842 Reduced 7.96%
9,738 $1.45 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $93,902 - $113,366
-729 Reduced 6.45%
10,580 $1.49 Million
Q1 2020

May 01, 2020

SELL
$111.14 - $153.99 $23,783 - $32,953
-214 Reduced 1.86%
11,309 $1.48 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $108,630 - $124,766
-852 Reduced 6.88%
11,523 $1.68 Million
Q3 2019

Oct 16, 2019

SELL
$126.95 - $142.14 $2.2 Million - $2.46 Million
-17,323 Reduced 58.33%
12,375 $1.6 Million
Q2 2019

Aug 07, 2019

BUY
$131.15 - $144.24 $2.24 Million - $2.47 Million
17,097 Added 135.68%
29,698 $4.14 Million
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $31,555 - $35,087
251 Added 2.03%
12,601 $1.76 Million
Q4 2018

Jan 25, 2019

BUY
$122.84 - $147.84 $8,353 - $10,053
68 Added 0.55%
12,350 $1.59 Million
Q3 2018

Oct 23, 2018

SELL
$121.58 - $142.88 $20,060 - $23,575
-165 Reduced 1.33%
12,282 $1.69 Million
Q2 2018

Aug 16, 2018

BUY
$119.4 - $131.76 $117,728 - $129,915
986 Added 8.6%
12,447 $1.51 Million
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $52,917 - $62,663
-423 Reduced 3.56%
11,461 $1.47 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $171,373 - $187,567
1,306 Added 12.35%
11,884 $1.66 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $1.37 Million - $1.43 Million
10,578
10,578 $1.38 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.